Active Ingredient: DIHYDROERGOTAMINE MESYLATE
Proprietary Name: ATZUMI
Dosage Form; Route of Administration: POWDER; NASAL
Strength: EQ 5.2MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N217901
Product Number: 001
Approval Date: Apr 30, 2025
Applicant Holder Full Name: SATSUMA PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
